These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17290455)

  • 1. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study.
    Gurevich T; Peretz C; Moore O; Weizmann N; Giladi N
    Mov Disord; 2007 Apr; 22(6):880-3. PubMed ID: 17290455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin injections do not improve freezing of gait in Parkinson disease.
    Wieler M; Camicioli R; Jones CA; Martin WR
    Neurology; 2005 Aug; 65(4):626-8. PubMed ID: 16116132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injections to one leg alleviate freezing of gait in a patient with Parkinson's disease.
    Giladi N; Honigman S
    Mov Disord; 1997 Nov; 12(6):1085-6. PubMed ID: 9399243
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study.
    Giladi N; Gurevich T; Shabtai H; Paleacu D; Simon ES
    J Neurol; 2001 Jul; 248(7):572-6. PubMed ID: 11517998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type B for gait freezing in Parkinson's disease.
    Fernandez HH; Lannon MC; Trieschmann ME; Friedman JH
    Med Sci Monit; 2004 Jul; 10(7):CR282-4. PubMed ID: 15232500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
    Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease.
    Schneider SA; Edwards MJ; Cordivari C; Macleod WN; Bhatia KP
    Mov Disord; 2006 Oct; 21(10):1722-4. PubMed ID: 16817198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: a pilot study.
    Hamdy RC; Montpetit K; Raney EM; Aiona MD; Fillman RR; MacKenzie W; McCarthy J; Chafetz RS; Thomas SS; Tamayo CM; Littleton AG; Ruck-Gibis J; Takahashi SN; Rinaldi M; Finley GA; Platt RW; Dahan-Oliel N
    J Pediatr Orthop; 2009; 29(5):427-34. PubMed ID: 19568011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study.
    Freund BJ; Schwartz M
    J Rheumatol; 2000 Feb; 27(2):481-4. PubMed ID: 10685817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment.
    Cadeddu F; Bentivoglio AR; Brandara F; Marniga G; Brisinda G; Maria G
    Aliment Pharmacol Ther; 2005 Nov; 22(10):997-1003. PubMed ID: 16268975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
    Lew HL; Lee EH; Castaneda A; Klima R; Date E
    Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
    Voller B; Földy D; Hefter H; Auff E; Schnider P
    Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
    Nóbrega AC; Rodrigues B; Torres AC; Enzo A; Melo A
    J Neurol Sci; 2007 Feb; 253(1-2):85-7. PubMed ID: 17229441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A for drooling in Parkinson's disease: a pilot study to compare submandibular to parotid gland injections.
    Kalf JG; Smit AM; Bloem BR; Zwarts MJ; Mulleners WM; Munneke M
    Parkinsonism Relat Disord; 2007 Dec; 13(8):532-4. PubMed ID: 17383926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin A treatment for contouring of the lower leg.
    Han KH; Joo YH; Moon SE; Kim KH
    J Dermatolog Treat; 2006; 17(4):250-4. PubMed ID: 16971324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.